ValuentumAd

Official PayPal Seal














Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Dec 3, 2021
Best Idea Dollar General Announces Plans to Go International
Image Source: Dollar General Corporation – Fiscal 2020 Annual Report. We are big fans of Dollar General. The discount retailer has several big initiatives underway to extend its growth runway while boosting per store sales and enhancing its margins. Shares of DG have been treading water over the past few months after surging during the 2020 calendar year, though we still room for significant capital appreciation upside potential going forward. The company is a tremendous free cash flow generator, and we like shares of DG as an idea in the Best Ideas Newsletter portfolio.
Dec 3, 2021
Dividend Increases/Decreases for the Week December 3
Let's take a look at companies that raised/lowered their dividend this week.
Dec 2, 2021
Dividend Growth Idea Dick’s Sporting Goods Is Firing on All-Cylinders; Raises Guidance (Again) While Generating Gobs of Free Cash Flow
Image Source: Valuentum. On November 23, Dick’s Sporting Goods reported third quarter earnings for fiscal 2021 (period ended October 30, 2021) that beat both consensus top- and bottom-line estimates. The sporting goods retailer once again raised its full-year guidance for fiscal 2021 in conjunction with its latest earnings report. Dick’s Sporting Goods also raised its guidance when reporting its fiscal second quarter earnings back in August 2021 and its fiscal first quarter earnings back in May 2021, highlighting management’s growing confidence in the company’s near term performance. Though shares of DKS sold off following its latest earnings update, likely due to concerns over inflationary pressures and supply chain hurdles, Dick’s Sporting Goods’ outlook remains rock-solid. We continue to like the firm as an idea in the Dividend Growth Newsletter portfolio.
Dec 2, 2021
Best Idea Vertex Pharma Boosts Guidance (Again), Buying Back Stock While Awaiting Key Clinical Trials
Image Shown: Vertex Pharmaceuticals Inc is one of our favorite biotech ideas. Image Source: Vertex Pharmaceuticals Inc – Third Quarter of 2021 IR Earnings Presentation. Vertex Pharma has a robust drug pipeline, though all eyes are on its potential CTX001 treatment. Should the treatment receive the green light from key healthcare regulators, Vertex Pharma’s financial performance would benefit from a major growth catalyst. In the meantime, we think it is prudent for Vertex Pharma to continue leveraging its financial strength to repurchase sizable chunks of its stock. We like Vertex Pharma as an idea in the Best Ideas Newsletter portfolio.
Dec 1, 2021
Large Cap Growth Dominates, MLPs Have Suffered
Image: Sign up to our new options commentary. $1,000/year. 4 ideas per month and more! Image: Win = The options contract was closed as a win. Closed = the options contract was closed at a loss. Expired = The options contract expired worthless. Pie chart above does not consider ideas still open. Data through October 26, 2021. Results are hypothetical. No trading is taking place. Past performance is not indicative of future performance.On behalf of our team at Valuentum, we hope you had a wonderful Thanksgiving holiday weekend, and we wish you the very best this holiday season. We're hoping for a nice Santa Claus rally! Godspeed, and thank you for your membership and attention these past many years!
Nov 30, 2021
We Remain Bullish on Disney’s Capital Appreciation Upside Potential
Image Shown: Shares of The Walt Disney Company have shifted lower over the past month, though are still bullish on its capital appreciation upside. Our fair value estimate sits at $192 per share of Disney. The Walt Disney Company reported fourth-quarter earnings for fiscal 2021 (period ended October 2, 2021) on November 10 that missed consensus top- and bottom-line estimates. While the company’s ‘Disney Parks, Experiences and Products’ segment (includes its theme parks and resorts operations) staged an impressive turnaround last fiscal quarter, its ‘Disney Media and Entertainment Distribution’ segment (includes its video streaming businesses) grew at a slower pace than expected. Shares of Disney sold off after its latest earnings report, though we remain confident that the company’s free cash flow growth outlook remains stellar and continue to view Disney’s capital appreciation upside potential quite favorably. Disney is included as an idea in the Best Ideas Newsletter portfolio.
Nov 26, 2021
South32 Continues to Improve Its Asset Base
Image Source: South32 – October 2021 Sierra Gorda Acquisition IR Presentation. South32 represents one of our favorite ideas in the mining space, and we include shares of SOUHY as an idea in the new ESG Newsletter portfolio. We view both South32’s capital appreciation and income generation upside quite favorably, keeping in mind the firm has a variable dividend policy that is subject to foreign currency movements. On a scale of 1-100 (with 100 being the best), South32 earns a nice ESG rating of 93 (based on our proprietary ESG rating matrix) as the miner continues to pivot towards commodities that will be essential to making the green energy revolution possible.
Nov 26, 2021
ICYMI: Time to Consider Buying Chinese Equities? Not Exactly.
Image Shown: Shares of Alibaba Group have plummeted over the past year in the wake of Beijing’s crackdown on China’s domestic tech and fintech titans. Is it finally time to start loading up on Chinese equities? We don't think so.
Nov 26, 2021
Dividend Increases/Decreases for the Week November 26
Let's take a look at companies that raised/lowered their dividend this week.
Nov 24, 2021
Ameresco Has Soared, Boosts Guidance (Again)
Image Shown: Shares of Ameresco Inc have boomed higher since we first wrote about the company on V.com back in August 2020. We include Ameresco as an idea in our ESG Newsletter portfolio and see ample room for further capital appreciation upside. On November 1, Ameresco reported mixed third-quarter 2021 earnings that missed top-line consensus estimates but beat bottom-line numbers. The company also raised its full-year guidance (again) for 2021 which saw the firm increase the midpoint of its revenue, gross margin, non-GAAP adjusted EBITDA, and non-GAAP EPS forecast. Ameresco also raised its full-year guidance for 2021 when it published its first quarter 2021 earnings report. We include Ameresco as an idea in our new ESG Newsletter portfolio and shares of AMRC have surged higher in recent months. On the website, we first wrote about Ameresco back in August 2020 and shares of AMRC have roughly tripled since then as of this writing.



The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.